PTAB.US: Decisions of PTAB Patent Trial and Appeal Board Updated Daily.

Monday, March 12, 2018


custom search

Tech Center 1700 Chemical & Materials Engineering
1724 Ex Parte Pinon et al 13954825 - (D) HEANEY 102/103 Fletcher Yoder PC Johnson Controls, Inc. OHARA, BRIAN R

Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2894 Ex Parte Kiehlbauch 14848115 - (D) OWENS concurring NAGUMO 103 Wells St. John, P.S. TRAN, TONY

Tech Center 2400 Networking, Multiplexing, Cable, and Security
2454 Ex Parte Chatterjee 13796662 - (D) COURTENAY 103 103 MCCOY RUSSELL LLP PARK, JEONG S

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3695 Ex Parte BUNICK et al 14224991 - (D) LORIN 103 112(2)/101 41.50 112(2) FAY KAPLUN & MARCIN, LLP DONLON, RYAN D

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3769 Ex Parte Friedman et al 13841617 - (D) PRATS 103 MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP LUAN, SCOTT


Tech Center 1600 Biotechnology and Organic Chemistry
1638 E.I. DU PONT DE NEMOURS AND COMPANY Requester v. MONSANTO TECHNOLOGY LLC Patent Owner and Appellant Ex Parte 7943818 et al 11684413 95000690 - (D) GUEST 102/103 41.77 112(1) DENTONS US LLP THIRD-PARTY REQUESTER: DICKSTEIN SHAPIRO LLP CAMPELL, BRUCE R original O HARA, EILEEN B

Accordingly, accommodating the unpredictability in making minimally genetically modified soybean plants for achieving specific fatty acid content requires more explanation in order to have an enabled disclosure. Cf. In re Bowen, 492 F.2d 859, 862 (Cust. & Pat. App. 1974) (“In cases involving unpredictable factors, such as most chemical reactions and physiological activity, the scope of enablement obviously varies inversely with the degree of unpredictability of the factors involved.”).

Bowen, In re, 492 F.2d 859, 181 USPQ 48 (CCPA 1974) 2164.04

No comments :